Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver Health
作者机构:Department of Gastroenterology and HepatologyErasmus MC-University Medical CenterRotterdamthe Netherlands
出 版 物:《Journal of Clinical and Translational Hepatology》 (临床与转化肝病杂志(英文版))
年 卷 期:2024年第12卷第8期
页 面:750-754页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题:Alcohol use disorder Alcohol-associated liver disease Addiction pharmacotherapy Under treatment Metabolic dysfunctions Liver health Multidisciplinary clinics
摘 要:Both alcohol-associated liver disease(ALD)and metabolic dysfunction-associated steatotic liver disease are leading contributors to chronic liver *** conditions often coexist,exacerbating disease *** ALD being a leading cause of liver transplantation,many individuals with alcohol use disorder(AUD)do not receive *** this review,we discussed the epidemiology of ALD in AUD,various treatment options for AUD,and their efficacy on liver *** critical analysis of current evidence underscores the need for integrated models involving multiple stakeholders to improve ALD management.